塞力医疗
(603716)
| 流通市值：13.49亿 | | | 总市值：13.49亿 |
| 流通股本：2.01亿 | | | 总股本：2.01亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,529,479,856 | 1,010,864,711.19 | 444,069,353.53 | 2,308,631,655.32 |
| 营业收入 | 1,529,479,856 | 1,010,864,711.19 | 444,069,353.53 | 2,308,631,655.32 |
| 二、营业总成本 | 1,527,156,297.23 | 994,859,347.94 | 455,311,016.55 | 2,322,527,734.49 |
| 营业成本 | 1,214,470,004.09 | 787,298,653.68 | 344,956,616.06 | 1,850,068,015.04 |
| 税金及附加 | 6,106,316.17 | 4,117,394.65 | 1,750,451.31 | 10,703,621.8 |
| 销售费用 | 93,480,054.04 | 62,680,585.5 | 32,039,910.17 | 135,333,544.87 |
| 管理费用 | 134,090,301.1 | 87,458,952.47 | 49,619,178.41 | 208,628,378.2 |
| 研发费用 | 27,362,017.64 | 16,239,322.66 | 7,450,644.9 | 29,447,205.1 |
| 财务费用 | 51,647,604.19 | 37,064,438.98 | 19,494,215.7 | 88,346,969.48 |
| 其中:利息费用 | 56,255,020.87 | 39,304,067.21 | 19,010,682.5 | 98,760,044.78 |
| 其中:利息收入 | 6,510,763.42 | 2,748,019.31 | 986,660.77 | 19,363,490.16 |
| 加:公允价值变动收益 | 6,104,315.41 | 4,703,105.88 | - | - |
| 加:投资收益 | 1,242,797.28 | -499,771.86 | 1,047,869.24 | -5,950,930.48 |
| 资产处置收益 | -1,744,284.86 | -106,732.91 | -38,885.37 | -22,696.71 |
| 资产减值损失(新) | -1,605,894.77 | -1,490,481.82 | -672,769.22 | -39,820,573.42 |
| 信用减值损失(新) | 7,635,911.23 | -3,149,843.12 | -343,764.9 | -91,920,743.71 |
| 其他收益 | 2,484,532.55 | 2,427,386.54 | 710,921.15 | 3,085,553.76 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 16,440,935.61 | 17,889,025.96 | -10,538,292.12 | -148,525,469.73 |
| 加:营业外收入 | 2,242,105.18 | 1,520,525.76 | 561,069.66 | 363,620.38 |
| 减:营业外支出 | 3,266,152.45 | 2,092,234.84 | 869,439.34 | 43,552,968.48 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 15,416,888.34 | 17,317,316.88 | -10,846,661.8 | -191,714,817.83 |
| 减:所得税费用 | -2,372,497.35 | 237,457.83 | -4,195,234.15 | -455,854.81 |
| 六、净利润 | 17,789,385.69 | 17,079,859.05 | -6,651,427.65 | -191,258,963.02 |
| 持续经营净利润 | 17,789,385.69 | 17,079,859.05 | -6,651,427.65 | -191,258,963.02 |
| 归属于母公司股东的净利润 | -3,814,605.05 | 1,530,552.56 | -14,907,815.02 | -154,417,230 |
| 少数股东损益 | 21,603,990.74 | 15,549,306.49 | 8,256,387.37 | -36,841,733.02 |
| (一)基本每股收益 | -0.02 | 0.01 | -0.07 | -0.79 |
| (二)稀释每股收益 | -0.02 | 0.01 | -0.07 | -0.79 |
| 八、其他综合收益 | -8,888,722.58 | -5,009,186.5 | -860,262.66 | 4,530,482.34 |
| 归属于母公司股东的其他综合收益 | -8,888,722.58 | -5,009,186.5 | -860,262.66 | 4,530,482.34 |
| 九、综合收益总额 | 8,900,663.11 | 12,070,672.55 | -7,511,690.31 | -186,728,480.68 |
| 归属于母公司股东的综合收益总额 | -12,703,327.63 | -3,478,633.94 | -15,768,077.68 | -149,886,747.66 |
| 归属于少数股东的综合收益总额 | 21,603,990.74 | 15,549,306.49 | 8,256,387.37 | -36,841,733.02 |
| 公告日期 | 2023-10-27 | 2023-08-30 | 2023-04-27 | 2023-04-27 |
| 审计意见(境内) | | | | 保留意见 |